Business Description
Hanx Biopharmaceuticals is a Chinese drug development company founded in 2014 and based in Wuhan, focused on creating new cancer treatments that work with the body's immune system. Its most advanced drug candidates target difficult-to-treat cancers such as melanoma, lymphoma, bile duct cancer, and brain tumors, with several compounds currently in clinical trials. The company has also built its own internal research platforms to discover and develop next-generation cancer and autoimmune therapies.
